Science Explorer Interactive view Map
Topic · Endocrinology, Diabetes and Metabolism

Hyperglycemia and glycemic control in critically ill and hospitalized patients

Hyperglycemia and glycemic control in critically ill and hospitalized patients is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 25k research works in it since 1950. 15.6% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the impact of hyperglycemia, the use of intensive insulin therapy, and glycemic control on health outcomes in critically ill and surgical patients, with a focus on infection risk, mortality, and the inflammatory response. It also investigates the association between hyperglycemia and various medical conditions such as myocardial infarction, stroke, and traumatic brain injury.

  • Hyperglycemia
  • Insulin Therapy
  • Critical Care
  • Infection Risk
  • Glycemic Control
  • Mortality
  • Diabetes Mellitus
  • Intensive Care Unit
  • Surgical Patients
  • Inflammatory Response
Research works
25k
fractional, since 1950
In the world top 10%
3.9k
per year above
Top-10% rate
15.6%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+19%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Hyperglycemia and glycemic control in critically ill and hospitalized patients research?

By volume, the United States and China publish the most (1.1k and 711 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.1k works
  2. 2 China 711 works
  3. 3 United Kingdom 238 works
  4. 4 India 228 works
  5. 5 Germany 149 works
  6. 6 Japan 144 works
  7. 7 Italy 118 works
  8. 8 Australia 112 works
  9. 9 Canada 103 works
  10. 10 Spain 93 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 36.4%China: 23.9%United Kingdom: 8.0%India: 7.6%6 others listed: 24.1%36%largest
United States1,083 · 36.4%China711 · 23.9%United Kingdom238 · 8.0%India228 · 7.6%6 others listed719 · 24.1%

Shares of the rows listed above, not of the whole node.

Which institutions lead Hyperglycemia and glycemic control in critically ill and hospitalized patients research?

By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Hyperglycemia and glycemic control in critically ill and hospitalized patients research, followed by Capital Medical University and University of North Carolina at Chapel Hill.

By volume, 2022–2025

  1. 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 20 works
  2. 2 Capital Medical UniversityChina 17 works
  3. 3 University of North Carolina at Chapel HillUnited States 15 works
  4. 4 Emory UniversityUnited States 14 works
  5. 5 University of PennsylvaniaUnited States 12 works
  6. 6 Nanjing Medical UniversityChina 12 works
  7. 7 Harvard UniversityUnited States 12 works
  8. 8 University of CopenhagenDenmark 11 works
  9. 9 Children's Hospital of PhiladelphiaUnited States 11 works
  10. 10 Ain Shams UniversityEgypt 11 works

Who are the leading researchers in Hyperglycemia and glycemic control in critically ill and hospitalized patients?

The most-cited researchers publishing on Hyperglycemia and glycemic control in critically ill and hospitalized patients include Harlan M. Krumholz, Deepak L. Bhatt and Piotr Ponikowski.

  1. 1 Harlan M. Krumholz United States 4.7k citations
  2. 2 Deepak L. Bhatt United States 4.2k citations
  3. 3 Piotr Ponikowski Poland 4.1k citations
  4. 4 Muthiah Vaduganathan United States 4k citations
  5. 5 Darren K. McGuire United States 3.6k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Hyperglycemia and glycemic control in critically ill and hospitalized patients research done?

The largest centres of Hyperglycemia and glycemic control in critically ill and hospitalized patients research in 2022–2025 are Beijing (China), London (United Kingdom), Guangzhou (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Copenhagen.

Largest cities, 2022–2025

  1. 1 Beijing China 118 works
  2. 2 London United Kingdom 61 works
  3. 3 Guangzhou China 52 works
  4. 4 Seoul South Korea 49 works
  5. 5 Shanghai China 49 works
  6. 6 Boston United States 43 works
  7. 7 New York United States 41 works
  8. 8 Philadelphia United States 39 works
  9. 9 Tokyo Japan 39 works
  10. 10 Copenhagen Denmark 37 works

Where it is the local speciality

  1. CopenhagenDK · 37.2 works5.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Hyperglycemia and glycemic control in critically ill and hospitalized patients than the world average.

See Hyperglycemia and glycemic control in critically ill and hospitalized patients on the map

Where is the best place to study Hyperglycemia and glycemic control in critically ill and hospitalized patients?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, Capital Medical University and University of Colorado Anschutz Medical Campus score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 30.02%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 20, 38.7%Capital Medical University: 17, 30.2%University of Colorado Anschutz Medical Campus: 10, 29.8%Harvard University: 12, 39.7%University of Auckland: 8, 27.5%Emory University: 14, 29.1%University of Copenhagen: 11, 28.1%Sun Yat-sen University: 10, 36.0%University of Padua: 9, 26.0%Nanjing Medical University: 12, 15.1%Harvard UniversityChinese Academy of M…Capital Medical Univ…University of Colora…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 65.938.7%5.0×20 +20.8%
2 Capital Medical UniversityChina 57.730.2%6.9×17 -7.6%
3 University of Colorado Anschutz Medical CampusUnited States 56.329.8%8.7×10 +51.2%
4 Harvard UniversityUnited States 53.039.7%2.2×12 +20.0%
5 University of AucklandNew Zealand 51.227.5%3.8×8 +155.8%
6 Emory UniversityUnited States 51.129.1%4.6×14 +49.8%
7 University of CopenhagenDenmark 48.428.1%3.8×11 +11.7%
8 Sun Yat-sen UniversityChina 38.536.0%1.4×10 +21.4%
9 University of PaduaItaly 37.326.0%2.6×9 +51.7%
10 Nanjing Medical UniversityChina 37.215.1%5.5×12 +42.9%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Hyperglycemia and glycemic control in critically ill and hospitalized patients research growing?

Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Hyperglycemia and glycemic control in critically ill and hospitalized patients.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.